Traditional colorectal cancer (CRC) screening tools, such as carcinoembryonic antigen (CEA) and the fecal immunochemical test (FIT), focus primarily on tumor markers or occult gastrointestinal bleeding. This evidence concerns the gene CEACAM5 and neoplasm.